5-Hydroxyeicosatetraenoic acid (5-HETE) Inhibitor

5-Hydroxyeicosatetraenoic acid (5-HETE) Inhibitor

User Options

Hover over an icon for more information

Additional Topics Details for this Page

Article Count - 1
Cumulative Knowledge - 1

Advanced Database Options

Limit Articles Displayed by the Following Study Types

What is Cumulative Knowledge?

Cumulative Knowledge is determined by ascribing a numerical value to the various study types weighted in descending order as follows: (1) Meta-Analysis; (2) Human Study; (3) Human: Case Study; (4) Animal: Transgenic; (5) Animal; (6) In Vitro; (7) Review; and (8) Commentary.

Click here for a more thorough explanation.

Quick Summary: 2 associated Substances

Name	Cumulative Knowledge	Article Count	Focus Articles
Resveratrol	1	1	Log in \| Sign up
Stilbenes	1	1	Log in \| Sign up

Currently Viewing Free Sample of Member Only Features

Although all 19,000+ articles on GreenMedInfo.com are made entirely free to view as an educational service to the public, we provide a powerful set of enhanced data comprehension and retrieval tools for subscribing members. Above you are viewing a free preview, limited to 2 rows, of the membership feature called "Cumulative Knowledge" (learn more).

The Focus Article Feature is not enabled.

Upgrading to the Member role gives you access to unlimited rows of Cumulative Knowledge data.

To Participate

Click here to login
Click here to create an account

View the Evidence: Pharmacological Actions

Stilbenes such as resveratrol down-regulate inflammation in leukocytes.

Click here to read the entire abstract

Pubmed Data : Biochim Biophys Acta. 1985 Apr 25;834(2):275-8. PMID: 3922423

Article Published Date : Apr 25, 1985

Study Type : In Vitro Study

Additional Links

Substances : Resveratrol : CK(977) : AC(590), Stilbenes : CK(128) : AC(92)

Diseases : Inflammation: Arachidonate Metabolism Associated : CK(2) : AC(2), Inflammation: Leukocyte : CK(2) : AC(2)

Pharmacological Actions : 5-Hydroxyeicosatetraenoic acid (5-HETE) Inhibitor : CK(1) : AC(1), 5-Lipoxygenase Inhibitor : CK(5) : AC(4), Anti-Inflammatory Agents : CK(1230) : AC(433), Cyclooxygenase Inhibitors : CK(64) : AC(32), Lipoxygenase Inhibitors : CK(26) : AC(15), Thromboxane (TXB) Inhibitors : CK(5) : AC(4), Thromboxane B2 Inhibitor : CK(2) : AC(2)

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.

Printer-friendly version
Send to friend
PDF version